Biological Safety Testing Market to Reach $16,411.1 Million in 2035, Growing at 10.3% CAGR

Biological Safety Testing market valued at $6,203.5 million in 2025 and is projected to reach $16,411.1 million by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The market comprises testing solutions and services designed to ensure the safety, purity, and quality of biologics, vaccines, and medical products. The market is experiencing strong global growth driven by the rising development of biologics and biosimilars, increasing regulatory requirements for product safety, and the expansion of vaccine manufacturing worldwide. Growth is further supported by the surge in cell and gene therapy pipelines, increasing outsourcing of testing services to specialized CROs/CDMOs, and the growing complexity of biopharmaceutical products requiring advanced analytical validation. Technological advancements in rapid microbial testing, automation, and molecular-based detection methods are enhancing testing efficiency and accelerating product approval timelines. According to global health organizations and industry data, the increasing volume of biologics production, coupled with stringent regulatory frameworks, has significantly strengthened the demand for biological safety testing solutions. Large-scale data from clinical trials, biomanufacturing processes, and regulatory submissions is playing a crucial role in ensuring product safety, optimizing testing workflows, and supporting global healthcare delivery systems.

Browse the full report description of “Biological Safety Testing Market Size, Share & Trends Analysis Report by Product & Services (Kits & Reagents, Instruments, and Testing Services) by Test Type (Sterility Testing, Endotoxin Testing, Bioburden Testing, Cell Line Authentication & Characterization, Adventitious Agent Detection, Residual Host Contaminant Detection, and Others) and by End User (Pharmaceutical & Biotechnology Companies, CROs / CDMOs, Academic & Research Institutes, and Medical Device Companies) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/biological-safety-testing-market

Key Statistics: Biological Safety Testing at a Glance

• Biologics account for over 35% of the global pharmaceutical pipeline, significantly driving demand for safety and quality testing solutions.
• More than 60% of biopharmaceutical companies outsource at least part of their safety testing to CROs/CDMOs to improve efficiency and compliance.
• Global vaccine production exceeds 5 billion doses annually, reinforcing the need for rigorous sterility, endotoxin, and contamination testing frameworks.

Key Innovators Driving Biological Safety Testing Transformation

The key players in the biological safety testing market include Charles River Laboratories International, Inc., Eurofins Scientific SE, Lonza Group AG, Merck KGaA, Thermo Fisher Scientific Inc, among others.

• In May 2025, Thermo Fisher Scientific introduced an advanced rapid sterility testing platform designed to significantly reduce testing time while maintaining high accuracy, supporting faster biologics release and improved manufacturing efficiency.
• In March 2025, Charles River Laboratories expanded its biologics safety testing portfolio with enhanced viral clearance and mycoplasma detection services, strengthening its capabilities to support complex biologic drug development.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product & Services
  • By Test Type
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Charles River Laboratories International, Inc., Eurofins Scientific SE, Lonza Group AG, Merck KGaA, Thermo Fisher Scientific Inc, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biological Safety Testing Market Report Segment

By Product & Services

• Kits & Reagents
• Instruments
• Testing Services

By Test Type

• Sterility Testing
• Endotoxin Testing
• Bioburden Testing
• Cell Line Authentication & Characterization
• Adventitious Agent Detection
• Residual Host Contaminant Detection
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• CROs / CDMOs
• Academic & Research Institutes
• Medical Device Companies

Global Biological Safety Testing Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biological-safety-testing-market